Published in Am J Pathol on June 25, 2010
HIV-associated nephropathy: pathogenesis. Curr Opin Nephrol Hypertens (2011) 1.07
Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children. Future Virol (2011) 0.85
Rapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN. Exp Mol Pathol (2012) 0.85
HIV-1 promotes renal tubular epithelial cell protein synthesis: role of mTOR pathway. PLoS One (2012) 0.83
MicroRNAs in HIV-associated nephropathy (HIVAN). Exp Mol Pathol (2012) 0.79
Tubular cell HIV-entry through apoptosed CD4 T cells: a novel pathway. Virology (2012) 0.78
mTOR plays a critical role in p53-induced oxidative kidney cell injury in HIVAN. Am J Physiol Renal Physiol (2013) 0.78
Constitutive activation of the mTOR signaling pathway within the normal glomerulus. Biochem Biophys Res Commun (2012) 0.75
Renin angiotensin system modulates mTOR pathway through AT2R in HIVAN. Exp Mol Pathol (2014) 0.75
Rapamycin-induced modulation of miRNA expression is associated with amelioration of HIV-associated nephropathy (HIVAN). Exp Cell Res (2013) 0.75
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell (2006) 18.36
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00
Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest (2003) 6.44
The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci U S A (2006) 4.56
Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med (2002) 4.05
TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell (1995) 3.56
Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. J Biol Chem (2005) 2.84
Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem (2007) 2.70
Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol (2004) 2.69
Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sci U S A (1992) 2.48
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int (2004) 2.42
Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int (2006) 2.24
The role of the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc Nephrol (2009) 2.05
Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy. J Am Soc Nephrol (2005) 2.00
cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc Natl Acad Sci U S A (1995) 1.97
S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol (2009) 1.74
Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int (2007) 1.63
Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression. J Clin Invest (2009) 1.49
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J (2002) 1.42
Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol (2008) 1.41
Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin. Am J Pathol (2007) 1.41
Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy. J Am Soc Nephrol (2005) 1.39
Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol (2007) 1.39
Nutrient sensing in the mTOR/S6K1 signalling pathway. Biochem Soc Trans (2007) 1.39
Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc Natl Acad Sci U S A (2004) 1.38
The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int (2008) 1.33
The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem Biophys Res Commun (2009) 1.31
mRNA translation: unexplored territory in renal science. J Am Soc Nephrol (2006) 1.22
Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion. J Pharmacol Exp Ther (2006) 1.18
Regulation of mRNA translation in renal physiology and disease. Am J Physiol Renal Physiol (2009) 1.13
The balance of autocrine VEGF-A and VEGF-C determines podocyte survival. Am J Physiol Renal Physiol (2009) 1.12
Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. Kidney Int (2006) 1.11
HIV-1 upregulates VEGF in podocytes. J Am Soc Nephrol (2008) 1.05
Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus. Kidney Int (2008) 1.04
The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat. Transplantation (2007) 0.99
Pulse mTOR inhibitor treatment effectively controls cyst growth but leads to severe parenchymal and glomerular hypertrophy in rat polycystic kidney disease. Am J Physiol Renal Physiol (2009) 0.98
The mTOR inhibitor everolimus attenuates the time course of chronic anti-Thy1 nephritis in the rat. Nephron Exp Nephrol (2008) 0.93
Human immunodeficiency virus downregulates podocyte apoE expression. Am J Physiol Renal Physiol (2009) 0.88
Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion. Transplant Proc (2009) 0.82
Rapamycin reduces proteinuria and renal damage in the rat remnant kidney model. Transplant Proc (2009) 0.81
Sirolimus delays recovery from posttransplant renal failure in kidney graft recipients. Transplant Proc (2005) 0.79
Sirolimus attenuates chronic allograft nephropathy in an experimental rat kidney transplantation model. Transplant Proc (2006) 0.77
A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol (2006) 2.05
Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease. Clin J Am Soc Nephrol (2012) 1.89
MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J Biol Chem (2011) 1.70
Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: a potential role in diabetic nephropathy. Kidney Int (2003) 1.68
Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes (2007) 1.61
AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem (2010) 1.60
Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats. Am J Physiol Heart Circ Physiol (2008) 1.52
CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice. J Clin Invest (2003) 1.52
Protease inhibitors modulate apoptosis in mesangial cells derived from a mouse model of HIVAN. Kidney Int (2004) 1.46
Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin. Am J Pathol (2007) 1.41
Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Arterioscler Thromb Vasc Biol (2011) 1.34
High glucose, high insulin, and their combination rapidly induce laminin-beta1 synthesis by regulation of mRNA translation in renal epithelial cells. Diabetes (2007) 1.32
Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol (2002) 1.31
Raptor-rictor axis in TGFbeta-induced protein synthesis. Cell Signal (2007) 1.28
Inhibition of p66ShcA longevity gene rescues podocytes from HIV-1-induced oxidative stress and apoptosis. J Biol Chem (2009) 1.24
mRNA translation: unexplored territory in renal science. J Am Soc Nephrol (2006) 1.22
Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis. Am J Nephrol (2008) 1.15
Regulation of mRNA translation in renal physiology and disease. Am J Physiol Renal Physiol (2009) 1.13
Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction. J Am Soc Nephrol (2006) 1.13
Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells. J Biol Chem (2011) 1.12
ANG II promotes autophagy in podocytes. Am J Physiol Cell Physiol (2010) 1.11
Endocytosis of light chains induces cytokines through activation of NF-kappaB in human proximal tubule cells. Kidney Int (2002) 1.11
microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion. PLoS One (2012) 1.11
Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol (2003) 1.07
Glycogen synthase kinase 3beta is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells. J Biol Chem (2008) 1.07
Role of p38 mitogen-activated protein kinase phosphorylation and Fas-Fas ligand interaction in morphine-induced macrophage apoptosis. J Immunol (2002) 1.05
Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms. Exp Mol Pathol (2013) 1.04
Morphine-induced macrophage apoptosis modulates migration of macrophages: use of in vitro model of urinary tract infection. J Endourol (2002) 1.03
Aldosterone as a mediator in cardiovascular injury. Cardiol Rev (2002) 1.03
HIV-induced kidney cell injury: role of ROS-induced downregulated vitamin D receptor. Am J Physiol Renal Physiol (2012) 1.03
Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension. Front Biosci (2008) 1.03
Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation. J Leukoc Biol (2004) 1.02
HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation. Am J Physiol Renal Physiol (2009) 1.01
Aldosterone promotes proximal tubular cell apoptosis: role of oxidative stress. Am J Physiol Renal Physiol (2007) 1.01
Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species. Am J Physiol Renal Physiol (2005) 1.01
Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence. Am J Pathol (2009) 1.00
Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy. Kidney Int Suppl (2002) 1.00
Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol Med (2002) 1.00
Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1. Cell Signal (2011) 0.99
Idiopathic nodular glomerulosclerosis in a non-diabetic hypertensive smoker--case report and review of literature. Nephrol Dial Transplant (2006) 0.99
Unrestrained mammalian target of rapamycin complexes 1 and 2 increase expression of phosphatase and tensin homolog deleted on chromosome 10 to regulate phosphorylation of Akt kinase. J Biol Chem (2011) 0.99
Novel mechanism of reducing tumourigenesis: upregulation of the DNA repair enzyme OGG1 by rapamycin-mediated AMPK activation and mTOR inhibition. Eur J Cancer (2010) 0.98
Activation of Notch signaling pathway in HIV-associated nephropathy. AIDS (2010) 0.97
Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II. Am J Physiol Renal Physiol (2004) 0.97
Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation. Mol Med (2007) 0.96
Aldosterone induces apoptosis in rat podocytes: role of PI3-K/Akt and p38MAPK signaling pathways. Nephron Exp Nephrol (2009) 0.95
DEC-205-mediated internalization of HIV-1 results in the establishment of silent infection in renal tubular cells. J Am Soc Nephrol (2007) 0.95
PRAS40 acts as a nodal regulator of high glucose-induced TORC1 activation in glomerular mesangial cell hypertrophy. J Cell Physiol (2010) 0.95
High glucose induces autophagy in podocytes. Exp Cell Res (2013) 0.95
Adverse host factors exacerbate occult HIV-associated nephropathy. Am J Pathol (2011) 0.94
Resveratrol ameliorates high glucose-induced protein synthesis in glomerular epithelial cells. Cell Signal (2009) 0.94
TGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion. PLoS One (2012) 0.94
Phospholipase Cgamma-Erk Axis in vascular endothelial growth factor-induced eukaryotic initiation factor 4E phosphorylation and protein synthesis in renal epithelial cells. J Biol Chem (2005) 0.93
HIV compromises integrity of the podocyte actin cytoskeleton through downregulation of the vitamin D receptor. Am J Physiol Renal Physiol (2013) 0.93
Mechanism of VEGF expression by high glucose in proximal tubule epithelial cells. Mol Cell Endocrinol (2009) 0.93
Tenofovir-induced kidney injury. Expert Opin Drug Saf (2007) 0.92
NFκB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation. Cell Signal (2013) 0.92
TSC2 deficiency increases PTEN via HIF1alpha. J Biol Chem (2009) 0.92
VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney Int (2005) 0.92
HIV-1 gp120-induced tubular epithelial cell apoptosis is mediated through p38-MAPK phosphorylation. Mol Med (2002) 0.91
Ethanol promotes T cell apoptosis through the mitochondrial pathway. Immunology (2003) 0.91
Resveratrol inhibits PDGF receptor mitogenic signaling in mesangial cells: role of PTP1B. FASEB J (2008) 0.91
Tubular cell HIV-1 gp120 expression induces caspase 8 activation and apoptosis. Ren Fail (2009) 0.91
Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen. Kidney Int (2004) 0.90
Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab (2003) 0.89
High glucose upregulation of early-onset Parkinson's disease protein DJ-1 integrates the PRAS40/TORC1 axis to mesangial cell hypertrophy. Cell Signal (2011) 0.89
Role of oxidative stress and heme oxygenase activity in morphine-induced glomerular epithelial cell growth. Am J Physiol Renal Physiol (2003) 0.89
Aldosterone induces mesangial cell apoptosis both in vivo and in vitro. Am J Physiol Renal Physiol (2008) 0.89
Erk in kidney diseases. J Signal Transduct (2011) 0.89
Human immunodeficiency virus downregulates podocyte apoE expression. Am J Physiol Renal Physiol (2009) 0.88
An improved small-molecule inhibitor of FtsZ with superior in vitro potency, drug-like properties, and in vivo efficacy. Antimicrob Agents Chemother (2012) 0.88
The type 2 vascular endothelial growth factor receptor recruits insulin receptor substrate-1 in its signalling pathway. Biochem J (2002) 0.88
Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney. Am J Physiol Cell Physiol (2013) 0.87
HIV-1 and kidney cells: better understanding of viral interaction. Nephron Exp Nephrol (2010) 0.87
Transforming growth factor β integrates Smad 3 to mechanistic target of rapamycin complexes to arrest deptor abundance for glomerular mesangial cell hypertrophy. J Biol Chem (2013) 0.87
Morphine modulates HIV-1 gp160-induced murine macrophage and human monocyte apoptosis by disparate ways. J Neuroimmunol (2004) 0.87
Essential oil composition of Thymus serpyllum cultivated in the Kumaon region of western Himalaya, India. Nat Prod Commun (2009) 0.86
Urinary proteomic analysis of chronic allograft nephropathy. Proteomics Clin Appl (2008) 0.86
Rapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN. Exp Mol Pathol (2012) 0.85
Regulation of protein synthesis by IGF-I in proximal tubular epithelial cells. Am J Physiol Renal Physiol (2002) 0.85
Islet-expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation. Eur J Immunol (2010) 0.85
Immunomodulatory effect of morphine: therapeutic implications. Expert Opin Drug Saf (2005) 0.85
Cocaine-induced renal disease. Expert Opin Drug Saf (2004) 0.85
HIV-1 harboring renal tubular epithelial cell interaction with T cells results in T cell trans-infection. Virology (2008) 0.85
Variation in the volatile constituents of Artemisia annua var. CIM-Arogya during plant ontogeny. Nat Prod Commun (2011) 0.85
Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab (2008) 0.85
Vancomycin-induced acute granulomatous interstitial nephritis: therapeutic options. Am J Med Sci (2007) 0.85
IQGAP1 mediates angiotensin II-induced apoptosis of podocytes via the ERK1/2 MAPK signaling pathway. Am J Nephrol (2013) 0.84
HIV gene expression deactivates redox-sensitive stress response program in mouse tubular cells both in vitro and in vivo. Am J Physiol Renal Physiol (2011) 0.84